Award recordCONTRACT

GILEAD SCIENCES INC

PIID 36C26019N0099· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $74,375 net obligations· UEI FPJMGUK1BYH8· CA

Description

LETAIRIS 5MG AND 10MG TABS

First action · last action
2018-10-01 · 2020-03-03
Transactions
2
First transaction's obligation
$77,350
Base + all options value (sum of deltas)
$74,375
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36E79718A0003
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$77,350$0Base award · 2018-10-01 · this action $77,350 · running total $77,350Modification P00001 · 2020-03-03 · this action -$2,975 · running total $74,375
  • Base2018-10-01+$77,350= $77,350
  • Mod P000012020-03-03-$2,975= $74,375
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-10-01+$77,350$77,350LETAIRIS 5MG AND 10MG TABS
Mod P00001· FUNDING ONLY ACTION2020-03-03−$2,975$74,375LETAIRIS 5MG AND 10MG TABS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FPJMGUK1BYH8)

AwardOffice · PSC / listingNet obligationsFY
36C26125N0499261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$14,894FY2025
36C26025F0137260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$3,103FY2025
36C26025F0134260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$2,482FY2025
36C24524N0911245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,938FY2024
36C26024F0466260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024
36C26024F0440260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26019N0099_3600_36E79718A0003_3600 · retrieved 2026-09-27.